Menu

Speaking of Cancer Research

A selection of notable quotes from the annual American Association for Cancer Research meeting

Apr 20, 2016
Tanya Lewis, Jef Akst, Mary Beth Aberlin

JEF AKST

This week in New Orleans, Louisiana, tens of thousands of scientists gathered to discuss the latest and greatest in the world of cancer research. Hot topics included cancer metabolism, neoantigens (antigens specific to tumor cells), epigenetic regulators of cancer, microRNAs, and more.

We are on the cusp of a real inflection point in the fight against cancer.

—US Vice President Joe Biden, in his remarks at AACR’s final plenary session “Highlights 2016: Vision for the Future”

I fear that I am a member of an endangered species at a time when the whole ethic of doing discovery-oriented research is being marginalized. . . . I hope that one day this trend will reverse itself.

Robert Weinberg, MIT, on receiving the 13th annual AACR Award for Lifetime Achievement in Cancer Research

I expect over the next decades we will see a very large expansion of the use of microRNAs to treat cancer. . . . It could be as large as monoclonal antibodies.

Phillip Sharp, MIT, in his opening comments at an AACR symposium on the roles of noncoding RNAs in cancer

The main message is that cancer immune-oncology is living up to its promise. Steady increase in durable remissions reported by a variety of groups. The main clinical challenge is how to efficiently conduct combination trials with other targeted agents, since preclinical models are pretty useless in predicting.

Carl June, University of Pennsylvania Perelman School of Medicine, in his talk at an AACR session on CAR T-cell therapy

So this suggests, contrary to what’s in every textbook, that our cells are capable of using extracellular proteins as a meaningful source of nutrients.

Craig Thompson, Memorial Sloan Kettering Cancer Center, during his plenary talk on cancer metabolism

The current understanding of what causes cancer focuses on the function of individual genes. . . . What’s missing in this picture is any discussion of aneuploidy.

Stephen Elledge, Harvard Medical School, in his AACR talk on aneuploidy and cancer

Data has been no more democratic than it is now. Take advantage of it to propel your own science.

Nancy Davidson, University of Pittsburgh Medical Center and incoming AACR president, in her talk on advice to young scientists

This is personal for us. . . . Our son Beau, my mother, my father. But it’s also bigger than us. It affects millions of people around the world, every day.

—US Second Lady Jill Biden in her remarks at AACR’s final plenary session “Highlights 2016: Vision for the Future”

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Complete Pathology Solutions: Make Every Minute Count

Complete Pathology Solutions: Make Every Minute Count

From sample collection and handling, to fixation and processing, tissue staining, and covering all your IHC and water purification needs—you can have confidence in the quality of your results with MilliporeSigma's one-stop pathology solution.

Preparing Cell Or Tissue Lysates For ELISA Kits

Preparing Cell Or Tissue Lysates For ELISA Kits

RayBiotech manufactures over 2,000 high fully validated, GMP-compliant ELISA kits. In this blog post we explain how to prepare cell or tissue lysates for ELISA Kits.

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Achieves Illumina Propel Certification as a Service Provider for Next Generation Sequencing

Norgen Biotek Corp., an innovative privately held Canadian biotechnology company focusing primarily on nucleic acid and protein stabilization and purification, as well as providing high quality services to the scientific community, today announced that it has become Propel-Certified through Illumina as a Next Generation Sequencing (NGS) service provider.

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.